Preterm birth is a public health concern. Each year in the U.S., nearly one in ten babies are born preterm…meaning less than 37 weeks of pregnancy or more than 3 weeks prior to the expected due date. That’s nearly 400,000 babies every year born too early in this country.
Preterm birth is a public health concern. Each year in the U.S., nearly one in ten babies are born preterm1…meaning less than 37 weeks of pregnancy or more than 3 weeks prior to the expected due date.2 That’s nearly 400,000 babies every year born too early in this country.3 Babies born preterm tend to develop more slowly, have more problems with their eyes, ears, breathing and nervous systems, and experience more learning and behavioral problems than full-term babies. Every week of pregnancy is important, including the last weeks. Because the brain and lungs are among the last organs to develop completely, late preterm birth babies also face potential complications associated with preterm birth.4
Click the orange play button below to listen
Preterm birth inflicts a significant financial, as well as emotional, toll on families. In 2007, the Institute of Medicine reported that the cost associated with premature birth in the United States was $26.2 billion each year.5 The average first-year medical costs, including inpatient and outpatient care, are approximately 10 times greater for preterm infants than for full-term infants.6
Speakers
Sean Daneshmand, MD
Clinical Professor, Department of Reproductive Medicine
University of California, San Diego
Dr. Sean Daneshmand is a practicing Maternal-Fetal medicine specialist in San Diego, CA since 2002. He received his undergraduate education at the University of California, Los Angeles and received his medical degree from New York Medical College. He completed his residence in Ob/Gyn at the University of California, Los Angeles and his fellowship in Maternal-Fetal medicine at the University of California, San Diego. He is also the founder of Miracle Babies, a non-profit organization providing financial assistance to families with newborns in the neonatal intensive care unit with chapters across the United States. He is currently in private practice at the San Diego Perinatal Center with teaching privileges at the University of California, San Diego.
AMAG Pharmaceuticals is a proud sponsor of Miracle Babies, founded by Dr. Daneshmand.
William M. Gilbert, MD
Regional Medical Director,
Women's Services Sutter Health Valley Region & Clinical Professor,
VCF Series Department of OB/GYN University of California, Davis
William M. Gilbert, MD is Regional Medical Director, Women's Services, Sutter Health Valley Region and Clinical Professor, Department of OB/GYN University of California, Davis. Dr Gilbert is the author of over 90 Peer reviewed publications and book chapters. His research interests include disorders of Amniotic Fluid Volume, epidemiological research on Maternal Medical Disorders and Quality indicators in Obstetrics. He has received numerous teaching awards of both Medical Students and Residents. He is the founding Co-Director of the Center for Perinatal Medicine and Law at UC Davis which works to educate Medical students, Residents and faculty on aspects of Medical Legal liability by giving interactive departmental Grand Rounds on this topic.
Dr. Gilbert is a consultant and speaker for AMAG Pharmaceuticals.
References
S1E4: Dr. Kristina Adams-Waldorf: Pandemics, pathogens and perseverance
July 16th 2020This episode of Pap Talk by Contemporary OB/GYN features an interview with Dr. Kristina Adams-Waldorf, Professor in the Department of Obstetrics and Gynecology and Adjunct Professor in Global Health at the University of Washington (UW) School of Medicine in Seattle.
Listen
Similar delivery times between misoprostol dosages among obese patients reported
May 29th 2024A recent study found that obese patients undergoing induction of labor experienced similar delivery times regardless of whether they received 50 μg or 25 μg of vaginal misoprostol, though multiparous patients showed faster delivery with the higher dosage.
Read More
Buprenorphine use in pregnancy linked to decreased fetal breathing movements
May 18th 2024According to a poster presented at ACOG 2024, use of the synthetic opioid buprenorphine depressed fetal breathing in biophysical profile assessments, but had no significant impact on other factors like amniotic fluid index or fetal tone.
Read More